TR200103039T2 - Asetilsalisilik asit ve klopidogrel hidrojenosülfat ihtiva eden bir birim formdaki farmasötik kompozisyon. - Google Patents

Asetilsalisilik asit ve klopidogrel hidrojenosülfat ihtiva eden bir birim formdaki farmasötik kompozisyon.

Info

Publication number
TR200103039T2
TR200103039T2 TR2001/03039T TR200103039T TR200103039T2 TR 200103039 T2 TR200103039 T2 TR 200103039T2 TR 2001/03039 T TR2001/03039 T TR 2001/03039T TR 200103039 T TR200103039 T TR 200103039T TR 200103039 T2 TR200103039 T2 TR 200103039T2
Authority
TR
Turkey
Prior art keywords
hydrogenosulfate
pharmaceutical composition
clopidogrel
unit form
acetylsalicylic acid
Prior art date
Application number
TR2001/03039T
Other languages
English (en)
Turkish (tr)
Inventor
Abramovici Bernard
Lheritier Jean
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of TR200103039T2 publication Critical patent/TR200103039T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR2001/03039T 1999-04-30 2000-04-25 Asetilsalisilik asit ve klopidogrel hidrojenosülfat ihtiva eden bir birim formdaki farmasötik kompozisyon. TR200103039T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9905497A FR2792836B3 (fr) 1999-04-30 1999-04-30 Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel

Publications (1)

Publication Number Publication Date
TR200103039T2 true TR200103039T2 (tr) 2002-01-21

Family

ID=9545071

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03039T TR200103039T2 (tr) 1999-04-30 2000-04-25 Asetilsalisilik asit ve klopidogrel hidrojenosülfat ihtiva eden bir birim formdaki farmasötik kompozisyon.

Country Status (24)

Country Link
EP (1) EP1178809A1 (es)
JP (1) JP2002543137A (es)
KR (1) KR20020005735A (es)
CN (1) CN1359294A (es)
AR (1) AR023789A1 (es)
AU (1) AU4303600A (es)
BR (1) BR0010194A (es)
CA (1) CA2371231A1 (es)
CZ (1) CZ20013887A3 (es)
EA (1) EA200100959A1 (es)
EE (1) EE200100559A (es)
FR (1) FR2792836B3 (es)
HK (1) HK1041823A1 (es)
HU (1) HUP0202329A2 (es)
IL (1) IL145648A0 (es)
IS (1) IS6084A (es)
MX (1) MXPA01011071A (es)
NO (1) NO20015295L (es)
NZ (1) NZ514248A (es)
PL (1) PL351923A1 (es)
SK (1) SK15542001A3 (es)
TR (1) TR200103039T2 (es)
UY (1) UY26131A1 (es)
WO (1) WO2000066130A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL206138B1 (pl) 2000-12-25 2010-07-30 Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
JP4917255B2 (ja) * 2003-10-16 2012-04-18 第一三共ヘルスケア株式会社 サリチル酸類含有経口組成物
WO2005070464A2 (en) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
US20070003615A1 (en) * 2005-06-13 2007-01-04 Elan Pharma International Limited Nanoparticulate clopidogrel and aspirin combination formulations
KR20070009851A (ko) * 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
KR20070044323A (ko) * 2005-10-24 2007-04-27 에스케이케미칼주식회사 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제
EP2001449A2 (en) * 2006-04-05 2008-12-17 Cadila Healthcare Ltd. Modified release clopidogrel formulation
EP1900358A1 (en) * 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
HUP0600839A3 (en) * 2006-11-14 2008-09-29 Egis Gyogyszergyar Nyrt Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof
JP2011512406A (ja) * 2008-02-22 2011-04-21 ハナル バイオファーマ カンパニー リミテッド 複合製剤
CN101695496A (zh) * 2009-10-15 2010-04-21 苏春华 一种含有三氟柳和氯吡格雷的药物组合物
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
RU2484820C2 (ru) * 2011-02-24 2013-06-20 Общество с ограниченной ответственностью "Озон" Комбинированное лекарственное средство, являющееся ингибитором агрегации тромбоцитов
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
JP6004524B2 (ja) * 2012-07-11 2016-10-12 大原薬品工業株式会社 クロピドグレル硫酸塩含有錠剤の製造方法
WO2015015062A1 (fr) * 2013-08-02 2015-02-05 Sanofi Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel
CN104434932B (zh) * 2014-12-18 2017-05-24 成都苑东生物制药股份有限公司 一种硫酸氢氯吡格雷阿司匹林片药物组合物及其制备方法
WO2017037741A1 (en) * 2015-09-02 2017-03-09 Sun Pharmaceutical Industries Ltd Compact solid dosage form of aspirin and clopidogrel
CN115737578A (zh) * 2022-11-23 2023-03-07 石家庄四药有限公司 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
FR2744918B1 (fr) 1996-02-19 1998-05-07 Sanofi Sa Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel

Also Published As

Publication number Publication date
CZ20013887A3 (cs) 2002-02-13
FR2792836A1 (fr) 2000-11-03
SK15542001A3 (sk) 2002-02-05
HK1041823A1 (zh) 2002-07-26
EE200100559A (et) 2003-02-17
WO2000066130A1 (fr) 2000-11-09
MXPA01011071A (es) 2002-07-22
AR023789A1 (es) 2002-09-04
NO20015295D0 (no) 2001-10-29
EP1178809A1 (fr) 2002-02-13
BR0010194A (pt) 2002-02-13
KR20020005735A (ko) 2002-01-17
JP2002543137A (ja) 2002-12-17
FR2792836B3 (fr) 2001-07-27
UY26131A1 (es) 2000-12-29
CA2371231A1 (en) 2000-11-09
CN1359294A (zh) 2002-07-17
IS6084A (is) 2001-09-25
IL145648A0 (en) 2002-06-30
NZ514248A (en) 2003-06-30
PL351923A1 (en) 2003-06-30
NO20015295L (no) 2001-12-21
AU4303600A (en) 2000-11-17
EA200100959A1 (ru) 2002-06-27
HUP0202329A2 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
TR200103039T2 (tr) Asetilsalisilik asit ve klopidogrel hidrojenosülfat ihtiva eden bir birim formdaki farmasötik kompozisyon.
BR9607128A (pt) Emulsão de aplicação tópica aperfeiçoada para carregar ácido ascórbico e ingredientes ativos solúveis em água e cápsula mole de getatina
ES2037866T3 (es) Una composicion desodorante en forma de gel.
ATE376413T1 (de) Verkapselung biologisch aktiver komplexe in liposomen
TR200002953T2 (tr) İki halkalı hidroksamik asit türevleri
IL152339A0 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
NO20031623L (no) Liposomal formulering av mitoxantron
TR200001645T2 (tr) Retinoyik asit taklidi anilürler.
IT1298918B1 (it) Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
TR200200982T2 (tr) Farmasötik bileşim terkipleri.
TR200000110T2 (tr) Dezenfekte edici bileşimler ve yüzeyleri dezenfekte etme yöntemleri.
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
ATE260092T1 (de) 5-aminolävulinsäure-nanoemulsion
IS5582A (is) Meta-asahringamínóbensósýrusambönd og afleiður þeirra reynast mótlyf við integríni.
TR200102259T2 (tr) Yeni oral formülasyon
TR200103427T2 (tr) Integrinlerin reseptörlerine bağlanmasını engelleyen propanoik asit türevleri.
DE59909341D1 (de) Retardformulierungen von pflanzenschutzwirkstoffen
CO4960657A1 (es) Composicion farmaceutica
HRP20010764B1 (en) Prucalopride oral solution
BR9812160A (pt) Derivados de benzoxazina e benzotiazina e seu emprego em medicamentos
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
EP1066816A4 (en) ACTIVE SUBSTANCES PROMOTE THE PRODUCTION OF LAMININE IN THE SKIN CELLS
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
PT1097159E (pt) Utilizacao de derivados de acidos fosfinicos e fosfonicos como medicamentos